Everus (NYSE:ECG) Price Target Raised to $78.00

Everus (NYSE:ECGFree Report) had its price objective lifted by Stifel Nicolaus from $71.00 to $78.00 in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock.

ECG has been the topic of a number of other research reports. Wolfe Research started coverage on Everus in a research note on Tuesday, December 3rd. They issued a “peer perform” rating on the stock. Oppenheimer assumed coverage on shares of Everus in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $70.00 price target on the stock. Finally, DA Davidson initiated coverage on shares of Everus in a research report on Monday, November 4th. They issued a “neutral” rating and a $55.00 price objective for the company.

View Our Latest Report on Everus

Everus Price Performance

Shares of NYSE ECG opened at $68.17 on Wednesday. Everus has a fifty-two week low of $40.05 and a fifty-two week high of $71.04. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.50 and a current ratio of 1.58.

About Everus

(Get Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Featured Articles

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.